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Abstract
Cardiovascular diseases (CVDs) are the leading cause of mortality and a major economic 
burden worldwide. Various drugs, including antihypertensive, antihyperlipidemic, and 
antiplatelet agents, are prescribed to treat CVDs, but these agents have side effects, includ-
ing serious side effects such as bleeding. Therefore, efforts are being made to develop 
new drugs made of natural substances with relatively weak side effects. Essential oils are 
natural substances extracted from aromatic plants with biological effects, such as antioxi-
dant and antiinflammatory activities. These oils have therefore long been used in tradi-
tional medicines. This chapter reviews the effects of essential oils on CVD-related factors. 
Essential oils have various effects, including improvements in lipid balance, liver func-
tion, and endothelial function; reductions in blood pressure, oxidative stress, thrombosis, 
and inflammation; promotion of vascular relaxation; and inhibition of diabetes devel-
opment and angiogenesis. Therefore, essential oils and their active components may be 
promising therapeutic agents for CVDs. Further studies are needed to clarify their clini-
cal effects and to elucidate their specific mechanisms of activity.
Keywords: essential oil, cardiovascular disease, dyslipidemia, hypertension, endothelial 
dysfunction
1. Introduction
Cardiovascular diseases (CVDs) are considered the leading cause of death worldwide. CVD-
related deaths accounted for 31.5% of all global deaths in 2013 [1]. In 2010, the global eco-
nomic burden of CVDs was 863 billion dollars, which was estimated to increase to 1044 billion 
dollars by 2030 [2]. Because the incidence of CVDs increases with age [3], the aging of society 
is expected to increase problems caused by CVDs. Traditional risk factors for CVDs, including 
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dyslipidemia, hypertension, and diabetes, cause oxidative stress. Fatty liver due to hyper-
lipidemia is also associated with increased lipid peroxidation [4]. Oxidative stress impairs 
vascular endothelial function, which is characterized by reduced nitric oxide (NO) bioavail-
ability. Vascular dysfunction contributes to the impairment of vascular tone, characterized 
by a decrease in endothelium-dependent vasorelaxation [5]. Because endothelium-derived 
NO inhibits leukocyte adhesion, which causes inflammation [6] and inhibits platelet adhe-
sion [7], endothelial dysfunction can lead to vascular inflammation and thrombosis. Activated 
platelets have been shown to increase inflammatory responses and the migration of vascular 
smooth muscle cells (SMCs) [8] (Figure 1).
Various drugs are prescribed to prevent and treat CVDs. For example, aspirin, clopidogrel, statins, 
beta-blockers and angiotensin converting enzyme (ACE) inhibitors are recommended for vascu-
lar protection in patients with stable angina [9]. Moreover, aspirin and statins have been reported 
to reduce the risks of atherosclerotic CVDs by 10 and 15%, respectively [10]. These drugs, how-
ever, have side effects [9]. For example, aspirin has been found to increase the risk of bleeding 
by 54% [10]. New drugs made of natural products with fewer side effects are therefore needed.
Essential oils are natural substances extracted from various organs of aromatic plants. Because 
these oils have pharmacological effects, they have been widely used in traditional medicines 
since the Middle Ages [11]. Studies have shown that essential oils and their main compo-
nents have various biological properties in relation to CVDs. For example, neroli essential 
oil showed vasorelaxant activity, mediated by the NO-soluble guanylyl cyclase pathway 
and by ryanodine receptors, in mouse aortic rings [12]. Bergamot essential oil also induced 
Figure 1. Flow chart showing the mechanisms of CVDs. Various risk factors increase levels of oxidative stress, thereby 
increasing endothelial dysfunction. Endothelial dysfunction, in turn, promotes abnormalities, such as impaired vascular 
tone, thrombosis, inflammation, and angiogenesis, which lead to CVDs.
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 vasorelaxation by inhibiting Ca2+ influx into mouse aortic rings [13]. The compound 1,8-cine-
ole, a main component of eucalyptus essential oil, showed antioxidative and antihypertensive 
effects in chronic nicotine-induced hypertensive rats [14]. These findings have led to efforts 
to determine the efficacy and specific mechanisms of action of essential oils on CVDs. This 
review therefore describes the results of studies assessing the effects of essential oils on CVDs 
and provides new perspectives on future drug development using essential oils.
2. Effects of essential oils
The effects of essential oils on CVDs are summarized in Table 1.
2.1. Dyslipidemia
Dyslipidemia is a major risk factor for CVDs. Reductions in low density lipoprotein cholesterol 
(LDL-C) levels have been associated with decreased risks of major vascular events [53], whereas 
elevated triglyceride (TG) level and total cholesterol (TC)/high density lipoprotein cholesterol 
(HDL-C) ratios have been associated with increased risks of coronary heart disease, regardless 
of LDL-C levels [54]. Essential oils have been shown to improve blood lipid levels. For example, 
Allium cepa and A. sativum essential oils were found to reduce serum cholesterol and serum TG 
levels and β/α lipoprotein ratios in cholesterol-fed rabbits, suggesting that these oils have anti-
atherosclerotic properties [16]. Dendropanax morbiferus essential oil also showed antiatherogenic 
activity by reducing plasma TC, TG, and LDL-C levels and by increasing plasma HDL-C levels in 
high-cholesterol fed rats [26]. Similarly, Syzygium aromaticum essential oil significantly improved 
dyslipidemia by reducing plasma TC, TG, and LDL-C levels and by increasing plasma HDL-C 
levels in rats with metabolic syndrome induced by a high fructose diet [4]. Supplementation of 
a hyperlipemic diet with Oenothera biennis essential oil reduced plasma TG and TC levels and 
increased plasma HDL-C levels [43, 44], and intake of Linum usitatissimum L. essential oil reduced 
blood TC, TG, and LDL-C levels, in patients diagnosed with metabolic syndrome [34].
Efforts have been made to determine the specific mechanisms by which essential oils improve 
lipid metabolism. Curcuma longa L. essential oil improved dyslipidemia in hyperlipidemic 
rats by modulating the expression of peroxisome proliferator-activated receptor-α, liver X 
receptor-α, sterol regulatory element-binding protein (SREBP)-2, 3-hydroxy-3-methylgluta-
ryl-CoA reductase (HMGCR) and genes involved in lipid regulation in the liver [24]. Oral 
administration of Nigella sativa essential oil to hyperlipidemic rats significantly reduced 
plasma TG levels and increased plasma HDL-C levels by reducing liver HMGCR activity [39]. 
Treatment of human hepatoma (HepG2) cells with Pinus koraiensis essential oil suppressed the 
expression of lipid-related genes, such as SREBP-1c, SREBP-2, HMGCR, fatty acid synthase, 
and glycerol-3-phosphate acyltransferase, increased the expression of low density lipoprotein 
receptors and inhibited the activation of human acyl-coenzyme A: cholesterol acyltransferases 
(hACAT) 1 and 2 [47]. Treatment of HepG2 cells with Lippia alba essential oil, especially the 
tagetenone chemotype, decreased lipid synthesis, lipid contents, and volume of lipid drop-
lets via the mevalonate pathway [35]. Also, incubation of HepG2 cells with Artemisia princeps 
essential oil significantly increased LDL-R expression [21].
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Essential oil Subject/route Effects Disease /model Main component Reference
Aframomum 
melegueta, 
Aframomum 
danielli
Pancreas and heart 
of rat
• Anti-diabetes
• Anti-oxidation
• ACE inhibition
— A. melegueta: eugenol 
(82.2%) A. danielli: 
eugenol (51.1%)
[15]
Allium cepa, 
Allium sativum
Indian albino 
rabbit /PO
• Fibrinolysis
• Lipid 
improvement
Athero sclerosis Allium cepa: dimethyl-
trisulfide (16.6%)
Allium ativum: diallyl-
trisulfide (33.6%)
[16]
Allium sativum Human/PO • Fibrinolysis Myocardial 
infarction
Diallyl-trisulfide 
(33.6%)
[17]
Alpinia zerumbet Wistar rat/IV • Blood pressure 
reduction
Hyper tension Terpinen-4-ol (28.1%) [18]
Alpinia zerumbet Wistar rat/PO, 
thoracic aorta of 
Wistar rat
• Blood pressure 
reduction
• Vasorelaxation
Hyper tension Terpinen-4-ol (57.4%) [19]
Aniba rosaeodora Wistar rat/IV, 
thoracic aorta of 
Wistar rat
• Blood pressure 
reduction
• Vasorelaxation
— Linalool (87.7%) [20]
Artemisia 
princeps
HepG2 cells, 
isolated human 
LDL
• Anti-oxidation
• Lipid 
improvement
— 1,8-cineole (20.1%) [21]
Citrus bergamia 
Risso
MOVAS cells, 
EA.hy926 cells
• Intracellular 
calcium influx 
inhibition
— d-Limonene (43.5%) [22]
Citrus bergamia 
Risso
Wistar rat/IP • Anti-oxidation
• Angiogenesis 
inhibition
Vascular injury d-Limonene (43.5%) [23]
Curcuma 
longa L.
Golden Syrian 
hamster/PO
• eNOS 
expression
• Anti-platelet
• Lipid 
improvement
• Liver function 
improvement
• Vasorelaxation
Hyper 
lipidemia
Ar-turmerone (20.5%) [24]
Curcuma 
longa L.
Wistar rat/PO, 
EA.hy926 cells
• Anti-
inflammation
Myocardial 
ischemia/
reperfusion 
injury
Ar-turmerone (20.5%) [25]
Dendropanax 
morbiferus
Wistar rat/PO • Lipid 
improvement
Hyper 
lipidemia
γ-Elemene (18.6%) [26]
Euphorbiaceae Wistar rat/IV, 
thoracic aorta of 
Wistar rat
• Blood pressure 
reduction
• Vasorelaxation
Hyper tension Hexadecanoic acid, 
ethyl ester (46.1%)
[27]
Foeniculum 
vulgare
Swiss mouse/SC, 
thoracic aorta of 
Wistar rat, Guinea 
pig plasma
• Anti-platelet
• Anti-thrombosis
• Vasorelaxation
Pulmonary 
thrombo 
embolism
Anethole (75.8%) [28]
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Essential oil Subject/route Effects Disease /model Main component Reference
Fructus Alpiniae 
zerumbet
HUVECs • Anti-
inflammation
High glucose 
induced injury
β-Phellandrene 
(16.4%)
[29]
Fructus Alpiniae 
zerumbet
HUVECs • Anti-oxidation oxLDL induced 
injury
β-Phellandrene 
(16.4%)
[30]
Hyptis fruticosa 
Salzm
Wistar rat/
IV, superior 
mesenteric 
artery of Wistar  
rat
• Blood pressure 
reduction
• Vasorelaxation
— 1,8-Cineole (16.9%) [31]
Lavandula 
hybrida
Human/Inhalation • Endothelial 
function 
improvement
— Linalyl acetate 
(36.2%)
[32]
Lavandula 
hybrida
Swiss mouse/PO, 
Guinea pig plasma
• Anti-platelet
• Anti-thrombosis
Pulmonary 
thrombo 
embolism
Linalyl acetate 
(36.2%)
[33]
Linum 
usitatissimum L.
Human/PO • Blood pressure 
reduction
• Lipid 
improvement
Metabolic 
syndrome
α-Linolenic acid 
(41.0% of total fatty 
acid)
[34]
Lippia alba HepG2 cells • Lipid 
improvement
— L. alba tagetenone: 
myrcenone  
(30.4%)
[35]
Mentha x villosa Wistar rat/IV • Blood pressure 
reduction
Hyper tension Piperitenone oxide 
(95.9%)
[36]
Mentha x villosa Wistar rat/IV, 
thoracic aorta of 
Wistar rat
• Blood pressure 
reduction
• Vasorelaxation
— Piperitenone oxide 
(95.9%)
[37]
Nardostachys 
jatamasi
Thoracic aorta of 
Sprague-Dawley 
rat, HUVECs
• Vasorelaxation
• NO production 
increase
— Calarene (38%) [38]
Nigella sativa Wistar albino rat/
PO
• Lipid 
improvement
• Anti-oxidation
Hyper 
lipidemia
Thymol (32.0%) [39]
Ocimum 
gratissimum
Wistar rat/IV, 
thoracic aorta of 
Wistar rat
• Blood pressure 
reduction
• Vasorelaxation
Hyper tension Eugenol (43.7%) [40]
Ocimum 
gratissimum
Wistar rat/IV • Blood pressure 
reduction
Hyper tension Eugenol (43.7%) [41]
Ocotea quixos Swiss mouse/
SC, thoracic aorta 
of Wistar rat, 
Guinea pig  
plasma
• Anti-platelet
• Anti-thrombosis
• Vasorelaxation
Pulmonary 
thrombo 
embolism
Trans-
cinnamaldehyde 
(27.8%)
[42]
Oenothera 
biennis
Rabbit/PO • Anti-platelet
• Angiogenesis 
inhibition
• Lipid 
improvement
Hyper 
lipidemia
Linoleic acid (71% of 
total fatty acid)
[43]
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Essential oil Subject/route Effects Disease /model Main component Reference
Oenothera 
biennis
New Zealand 
rabbit/PO
• Anti-oxidation
• Anti-platelet
• Anti-thrombosis
• Lipid 
improvement
Athero sclerosis Linoleic acid (71% of 
total fatty acid)
[44]
Oenothera 
biennis, Ribes 
nigrum, Borago 
officinalis
Spontaneously 
hyper tensive rat/
PO
• Blood pressure 
reduction
Hyper tension Oenothera biennis: 
linoleic acid (71.0% of 
total fatty acid) Ribes 
nigrum: linoleic acid 
(45.0% of total fatty 
acid) Borago officinalis: 
linoleic acid (36.0% of 
total fatty acid)
[45]
Olea Human/PO • Blood pressure 
reduction
• Anti-oxidation
• Endothelial 
function 
improvement
High-normal 
BP, stage 1 
essential HTN
oleic acid (55–83% of 
total fatty acid)*
[46]
Pinus koraiensis HepG2 cells • Anti-oxidation
• Lipid 
improvement
— Camphene (21.1%) [47]
Radix Angelica 
sinensis
HUVECs • Angiogenesis 
inhibition
— 3-Carene (32.1%) [48]
Rosa indica L. Thoracic aorta of 
rabbit
• Vasorelaxation — Acetic acid 
(percentage was not 
available)
[49]
Schisandra 
chinensis
HASMCs • Anti-oxidation
• Anti-
inflammation
• Angiogenesis 
inhibition
TNF-α induced 
injury
Borneol (43.6%) [50]
Syringa 
pinnatifolia 
Hems1. var. 
alashanesis
Wistar rat/IG Kun 
ming mouse/IP 
Primary cultured 
rat myocyte
• Anti-oxidation
• Anti-platelet
Myocardial 
infarction, 
hypoxia 
damage
α-Cadinol (19.9%) [51]
Syzygium 
aromaticum
Sprague-Dawley 
rat/PO
• Anti-oxidation
• Anti-
inflammation
• Lipid 
improvement
• Liver function 
improvement
Metabolic 
syndrome
Eugenol (75.2%) [4]
Trachyspermum 
ammi
Thoracic aorta of 
Wistar albino rat
• Vasorelaxation — Thymol (38.1%) [52]
*Polyphenol-rich olive oil was used in this study.
Table 1. Effects of essential oils in CVDs.
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2.2. Hypertension
Hypertension is also a major risk factor for CVDs. In the United States, the prevalence of 
hypertension in adults aged over 60 years was 67.2% from 2011 to 2014 and hypertension 
was the third leading cause of death from CVDs [55]. Thus, aggressive blood pressure control 
is needed and essential oils are thought to be helpful. Intragastric administration of Alpinia 
zerumbet essential oil to N-nitro-l-arginine methyl ester (l-NAME)-induced hypertensive rats 
for 30 days reduced systolic arterial pressure, diastolic arterial pressure, and mean arterial 
pressure in a time-dependent manner. These hypotensive effects of A. zerumbet essential oil 
were due to its vasorelaxing and Ca2+ antagonist effects [19]. In spontaneously hypertensive 
rats, Ribes nigrum essential oil reduced systolic blood pressure (SBP) significantly when com-
pared with sesame oil [45]. Although Oenothera biennis and Borago officinalis essential oils also 
reduced SBP, these effects were not statistically significant. In addition, intravenous adminis-
tration of Ribes nigrum essential oil reduced mean arterial pressure (MAP) in spontaneously 
hypertensive rats. Intravenous administration of Alpinia zerumbet [18], Euphorbiaceae [27], 
Mentha x villosa [36], and Ocimum gratissimum [40, 41] essential oils to deoxycorticosterone-
acetate (DOCA)-salt induced hypertensive rats, reduced MAP. Moreover, Aniba rosaeodora 
[20], Hyptis fruticosa Salzm [31], and Mentha x villosa essential oils [37] reduced MAP in nor-
motensive rats.
The antihypertensive effects of essential oils have also been demonstrated in human studies. 
In a randomized controlled trial, oral administration of Linum usitatissimum L. essential oil 
significantly reduced SBP and diastolic blood pressure (DBP) in patients with metabolic syn-
drome [34]. In addition, polyphenol-rich Olea essential oil reduced SBP and DBP in women 
diagnosed with stage 1 hypertension and those with high-normal blood pressure [46].
2.3. Fatty liver
Several essential oils effective in the treatment of dyslipidemia also improved liver fat contents 
and liver function. Oral administration of Syzygium aromaticum essential oil, the main compo-
nent of which is eugenol, to rats fed a high fructose diet, was found to reduce total fat, TC, and 
TG levels in the liver. In addition, S. aromaticum essential oil reduced the plasma concentrations 
of alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin and direct 
bilirubin in these rats, thereby improving fatty liver and liver dysfunction [4]. Similarly, oral 
administration of Curcuma longa L. essential oil to hyperlipidemic hamsters not only reduced 
hepatic cholesterol levels but also decreased plasma ALT and AST concentrations [24].
2.4. Diabetes
Because chronic hyperglycemia associated with diabetes increases oxidative stress, a cause 
of vascular endothelial dysfunction, via several pathways such as polyol flux [56], the anti-
diabetic effect of essential oils is noteworthy. In vitro studies showed that the essential oils 
of Aframomum melegueta and A. danielli, the main component of which is eugenol, had anti-
diabetic properties. Although both essential oils inhibited α-glucosidase and α-amylase, 
A. melegueta essential oil had much higher inhibitory activities, indicating greater antidiabetic 
effects, than A. danielli oil [15].
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2.5. Oxidative stress
Excessive production of reactive oxygen species (ROS) induces endothelial dysfunction, an 
early stage of atherosclerosis [57]. Patients with coronary artery disease (CAD) have higher 
lipid peroxidation activity but significantly lower antioxidant enzyme activities than indi-
viduals without CAD [58], indicating the importance of maintaining a balance between ROS 
production and antioxidant defense systems. Several essential oils have shown the ability to 
reduce oxidative stress. For example, pretreatment of human aortic SMCs with Schisandra chi-
nensis essential oil blocked tumor necrosis factor (TNF)-α-induced ROS [50]. Fructus Alpiniae 
zerumbet oil attenuated oxidative stress in human umbilical vein endothelial cells (HUVECs) 
exposed to ox-low density lipoprotein (LDL), not only by reducing malondialdehyde (MDA) 
contents but also by increasing the activities of antioxidant enzymes such as superoxide dis-
mutase (SOD), glutathione peroxidase, and catalase [30].
Essential oils have also been shown to be active in models of acute myocardial ischemia. For 
example, Syringa pinnatifolia Hems1. var. alashanesis essential oil inhibited the reduction of SOD 
activity and increased mitochondrial activity in cardiac myocytes [51]. Aframomum melegueta 
and A. danielli essential oils showed radical scavenging activity, as well as dose-dependently 
ameliorating lipid peroxidation in rat heart and pancreas [15]. Similarly, Artemisia princeps 
essential oil displayed radical scavenging activity and inhibited the production of thiobarbi-
turic acid-reactive substances, a marker of LDL oxidation [21]. Pinus koraiensis [47] and Olea 
essential oils [46] also inhibited LDL oxidation.
In addition, essential oils have also been found to reduce MDA contents. For example, Citrus 
bergamia Risso essential oil reduced MDA production in carotid arteries injured by balloon 
angioplasty [23] and Nigella sativa essential oil reduced plasma MDA formation in hyperlipid-
emic rats [39]. In rabbits, an atherogenic diet supplemented with Oenothera biennis essential oil 
inhibited platelet MDA production [44]. Oral administration of Syzygium aromaticum essential 
oil to rats with metabolic syndrome reduced plasma MDA concentrations [4].
2.6. Endothelial dysfunction
NO is a typical vasodilatory substance produced from l-arginine by the enzyme endothelial 
NO synthase (eNOS) in vascular endothelial cells [59]. Thus, endothelial dysfunction is asso-
ciated with decreased NO bioavailability [57]. In hyperlipidemic hamsters, Curcuma longa L. 
essential oil, at a concentration of 300 mg/kg body weight, increased the expression of aortic 
eNOS, suggesting that C. longa L. essential oil protects against endothelial dysfunction [24]. 
Treatment of HUVECs with Nardostachys jatamansi essential oil increased NO production by 
phosphorylating eNOS, a reaction mediated by the phosphatidylinositol 3-kinase/protein 
kinase B signaling pathway and changes in intracellular Ca2+ [38]. Aframomum melegueta and A. 
danielli essential oils were found to inhibit ACE activity in vitro, suggesting that these oils have 
antihypertensive activity, with A. danielli oil having greater activity than A. melegueta oil [15].
Flow mediated dilatation (FMD) is a widely used marker of vascular endothelial cell function. 
A study of night-shift medical workers found that FMD was significantly higher after a 30 min 
inhalation of Lavandula hybrida essential oil than before inhalation and than in a control group 
Potential of Essential Oils136
[32]. A randomized crossover study in women with stage 1 hypertension or high-normal BP 
found that a diet containing polyphenol-rich Olea essential oil increased hyperemic areas after 
cuff-induced ischemia, another test of vascular endothelial function [46].
2.7. Impaired vascular tone
Many essential oils have been found to induce vascular relaxation in vitro. In a hyperlipidemic 
animal model, oral administration of Curcuma longa L. essential oil, at a dose of 300 mg/kg body 
weight for 28 days, restored acetylcholine-induced vasorelaxation, as well as increasing eNOS 
expression and decreasing cholesterol contents in the aorta [24]. Ocimum gratissimum essential 
oil showed partial endothelium-dependent vasorelaxing activity in aortic rings from DOCA-salt 
induced hypertensive rats. This vasorelaxant activity was mainly attributed to an inhibition of Ca2+ 
influx rather than Ca2+ release from the sarcoplasmic reticulum [40]. In addition, essential oils of 
Aniba rosaeodora [20], Euphorbiaceae [27], Foeniculum vulgare [28], Mentha x villosa [37], Nardostachys 
jatamasi [38], Rosa indica L. [49], and Trachyspermum ammi [52] were found to induce vasorelax-
ation in rat thoracic aorta pre-contracted with KCL or phenylephrine. In particular, the vasodila-
tory effects of Nardostachys jatamasi essential oil were mediated by increased NO production [38]. 
Ocotea quixos essential oil also relaxed aortic rings pre-contracted with U46619 [42]. Alpinia zerum-
bet essential oil was also shown to relax aortic rings pre-contracted with KCL or phenylephrine. A. 
zerumbet oil also inhibited CaCl
2
-induced vascular contraction, an effect resulting from the inhibi-
tion of Ca2+ influx through voltage-operated and receptor-operated Ca2+ channels [19]. Similarly, 
the treatment of the rat superior mesenteric artery with Hyptis fruticosa Salzm essential oil resulted 
in vascular relaxation and inhibition of CaCl
2
-induced vascular contraction in a concentration-
dependent manner [31]. Adequate regulation of cytosolic Ca2+ is important in maintaining vascu-
lar tone. Citrus bergamia Risso essential oil inhibited Ca2+ influx into HUVECs [22].
2.8. Thrombosis
Platelet aggregation and adhesion play important roles in thrombus formation. Curcuma longa 
L. essential oil has been shown to reduce hyperlipidemia-induced platelet activation by sup-
pressing platelet aggregation and adhesion in hyperlipidemic hamsters [24]. Other essential oils 
were found to inhibit platelet aggregation or adhesion. For example, essential oils of Foeniculum 
vulgare [28], Lavandula hybrida [33], and Ocotea quixos [42] not only inhibited agonist-induced 
platelet aggregation in vitro but also inhibited thrombin-induced clot retraction in guinea pig 
plasma. In addition, these three essential oils prevented paralysis in an animal model of acute 
pulmonary thromboembolism, indicating that these oils had antithrombotic activity. Syringa 
pinnatifolia Hems1. var. Alashanesis essential oil was found to inhibit agonist-induced platelet 
aggregation in rat whole blood. This result, together with its antioxidant effects, suggests that 
Syringa pinnatifolia Hems1. var. Alashanesis oil has cardioprotective activity [51]. In addition, an 
atherogenic diet enriched with Oenothera biennis essential oil reduced agonist-induced platelet 
aggregation in whole blood and platelet thromboxane B2 production, thereby inhibiting plate-
let activation [44]. Both Allium cepa and A. sativum essential oils have been shown to increase the 
fibrinolytic activity of garlic and onions in atherosclerotic rabbits [16]. In addition, A. sativum 
essential oil was found to significantly increase the fibrinolytic activity in patients with chronic 
myocardial infarction and in patients after acute myocardial infarction [17].
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2.9. Inflammation
The levels of expression of intercellular adhesion molecule (ICAM)-1 and vascular cell adhe-
sion molecule (VCAM)-1 in endothelial cells increase during inflammation [60], with the 
expression of these adhesion molecules being regulated by inflammatory cytokines such as 
interleukin (IL)-1 and TNF-α [61]. Several essential oils have been shown effective in inhibit-
ing this process. For example, the treatment of HUVECs exposed to high glucose with Fructus 
Alpiniae zerumbet essential oil was shown to reduce the secretion of IL-8, TNF-α, ICAM-1, and 
VCAM-1 by inhibiting nuclear factor kappa B (NF-κB) signaling, suggesting that this essen-
tial oil has endothelial protective effects [29]. Similarly, the treatment of human aortic SMCs 
with Schisandra chinensis essential oil decreased TNF-α-induced matrix metalloproteinase-9 
(MMP-9) activation, inducible NO synthase and cyclooxygenase-2 (COX-2) expression by 
inhibiting NF-κB signaling [50]. In an animal study, oral administration of Curcuma longa 
L. essential oil to rats exposed to myocardial ischemia/reperfusion injury reduced endothe-
lial cell-induced inflammation by decreasing the expression of E-selectin and ICAM-1 [25]. 
Similarly, Syzygium aromaticum essential oil reduced plasma TNF-α concentration in rats fed 
a high-fructose diet [4].
2.10. Angiogenesis
The proliferation and migration of vascular SMCs play essential roles in the pathophysi-
ological changes of cardiovascular systems. Radix angelica essential oil was found to dose-
dependently inhibit HUVEC proliferation and migration, and, at concentrations above 20 μg/
ml, to reduce endothelial tube formation, indicating that R. angelica essential oil has antiangio-
genic effects [48]. Similarly, Schisandra chinensis essential oil effectively decreased the TNF-α-
induced migration of human aortic SMCs. These findings, together with the antiinflammatory 
and antioxidant effects of this oil, suggested that Schisandra chinensis oil has antiatheroscle-
rotic activity [50].
Animal studies have also assessed the effects of essential oils on angiogenesis. For example, sup-
plementation of a hyperlipidemic diet with Oenothera biennis essential oil for 6 weeks reduced 
endothelial lesions of the aorta and neointimal proliferation of the arterial wall in rabbits [43]. 
Citrus bergamia Risso essential oil reduced the neointima/media ratio and the cross-sectional area 
of the carotid artery in rats that underwent balloon-induced vascular injury, with these effects 
accompanied by decreased expression of lectin-like receptor for oxidized LDL [23].
3. Conclusions
Essential oils are natural substances extracted from aromatic plants with biological proper-
ties, including antioxidant and antiinflammatory activities. This chapter reviewed the effects 
of essential oils on CVD-related factors. Evidence has shown that essential oils have multiple 
effects, improving lipid balance, liver function, and endothelial function; reducing blood pres-
sure, diabetes induction, and oxidative stress; enhancing vascular relaxation; and inhibiting 
thrombosis, inflammation, and angiogenesis. Essential oils and their active components may 
therefore be promising therapeutic agents for CVDs. Studies are needed to clarify the effects 
of these oils on patients and to elucidate their specific mechanisms of action.
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